CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade $ SingMedical - 5OTsg CFD

    Market is not available at the moment

    Market information is presented
    as of 2023-09-21

    • Summary
    Trading Conditions
    Spread 0.011
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.021226 %
    Charges from full value of position ($-4.03)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.021226%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.000692 %
    Charges from full value of position ($-0.13)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.000692%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency SGD
    Margin 5%
    Stock exchange Singapore
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 0.392
    Open* 0.397
    1-Year Change* 28.9%
    Day's Range* 0.392 - 0.397
    52 wk Range 0.28-0.40
    Average Volume (10 days) 1.36M
    Average Volume (3 months) 37.61M
    Market Cap 194.65M
    P/E Ratio 13.24
    Shares Outstanding 486.38M
    Revenue 105.26M
    EPS 0.03
    Dividend (Yield %) 1.625
    Beta 0.97
    Next Earnings Date N/A

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    Date Close Change Change (%) Open High Low
    Dec 19, 2022 0.392 -0.005 -1.26% 0.397 0.397 0.392
    Dec 16, 2022 0.392 -0.005 -1.26% 0.397 0.397 0.392
    Dec 15, 2022 0.392 -0.005 -1.26% 0.397 0.397 0.392
    Dec 14, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
    Dec 9, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
    Dec 8, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
    Dec 6, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
    Dec 2, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
    Dec 1, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
    Nov 29, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
    Nov 28, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
    Nov 25, 2022 0.392 0.000 0.00% 0.392 0.392 0.392
    Nov 22, 2022 0.392 0.010 2.62% 0.382 0.392 0.382
    Nov 21, 2022 0.382 -0.005 -1.29% 0.387 0.387 0.382
    Nov 18, 2022 0.387 0.000 0.00% 0.387 0.387 0.382
    Nov 17, 2022 0.382 0.000 0.00% 0.382 0.382 0.382
    Nov 16, 2022 0.387 0.000 0.00% 0.387 0.387 0.382
    Nov 15, 2022 0.382 0.000 0.00% 0.382 0.382 0.382
    Nov 11, 2022 0.382 0.000 0.00% 0.382 0.387 0.382
    Nov 10, 2022 0.387 0.005 1.31% 0.382 0.387 0.382

    $ SingMedical Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total revenue 100.84 87.34 94.672 85.069 68.001
    Revenue 100.84 87.34 94.672 85.069 68.001
    Cost of Revenue, Total 56.58 49.3 51.431 47.274 39.027
    Gross Profit 44.26 38.04 43.241 37.795 28.974
    Total Operating Expense 83.175 76.269 77.472 69.921 57.541
    Selling/General/Admin. Expenses, Total 28.229 23.97 26.128 23.087 18.8
    Interest Expense (Income) - Net Operating -0.03 -0.075 -0.1 -0.071 -0.059
    Unusual Expense (Income) 1.142 3.15 0.146 0.062 0.04
    Other Operating Expenses, Total -2.746 -0.076 -0.133 -0.431 -0.267
    Operating Income 17.665 11.071 17.2 15.148 10.46
    Interest Income (Expense), Net Non-Operating 0.405 -0.529 -1.016 -0.786 -0.977
    Net Income Before Taxes 18.07 10.528 16.069 14.104 9.483
    Net Income After Taxes 15.716 9.097 13.635 12.915 8.732
    Minority Interest -0.108 -0.367 0.026 0.013 -0.233
    Net Income Before Extra. Items 15.608 8.73 13.661 12.928 8.499
    Net Income 15.608 8.73 13.661 12.928 8.499
    Income Available to Common Excl. Extra. Items 15.608 8.73 13.661 12.928 8.499
    Income Available to Common Incl. Extra. Items 15.608 8.73 13.661 12.928 8.499
    Diluted Net Income 15.608 8.73 13.661 12.928 8.499
    Diluted Weighted Average Shares 484.059 482.844 508.501 472.419 427.795
    Diluted EPS Excluding Extraordinary Items 0.03224 0.01808 0.02687 0.02737 0.01987
    Diluted Normalized EPS 0.0343 0.02372 0.02704 0.02716 0.01937
    Other, Net 0 -0.014 -0.115 -0.258
    Dividends per Share - Common Stock Primary Issue 0.0065 0.004 0.004
    Dec 2021 Jun 2021 Dec 2020 Jun 2020 Dec 2019
    Total revenue 51.158 49.682 48.395 38.945 25.856
    Revenue 51.158 49.682 48.395 38.945 25.856
    Cost of Revenue, Total 29.175 27.405 26.268 23.032 14.366
    Gross Profit 21.983 22.277 22.127 15.913 11.49
    Total Operating Expense 42.5 40.675 42.275 33.994 21.667
    Selling/General/Admin. Expenses, Total 14.894 13.335 12.868 11.102 7.263
    Interest Expense (Income) - Net Operating -0.011 -0.019 -0.015 -0.06 -0.034
    Unusual Expense (Income) 0.011 -0.011 0.167 0.146
    Other Operating Expenses, Total -1.569 -0.035 2.987 -0.08 -0.074
    Operating Income 8.658 9.007 6.12 4.951 4.189
    Interest Income (Expense), Net Non-Operating 0.468 -0.063 0.313 -0.856 0.084
    Net Income Before Taxes 9.126 8.944 6.433 4.095 4.273
    Net Income After Taxes 7.989 7.727 5.614 3.483 3.61
    Minority Interest 0.429 -0.537 -0.338 -0.029 0.073
    Net Income Before Extra. Items 8.418 7.19 5.276 3.454 3.683
    Net Income 8.418 7.19 5.276 3.454 3.683
    Income Available to Common Excl. Extra. Items 8.418 7.19 5.276 3.454 3.683
    Income Available to Common Incl. Extra. Items 8.418 7.19 5.276 3.454 3.683
    Diluted Net Income 8.418 7.19 5.276 3.454 3.683
    Diluted Weighted Average Shares 485.474 482.644 482.947 482.741 506.48
    Diluted EPS Excluding Extraordinary Items 0.01734 0.0149 0.01092 0.00715 0.00727
    Dividends per Share - Common Stock Primary Issue 0.0065 0 0.004 0 0.004
    Diluted Normalized EPS 0.01733 0.01487 0.01122 0.00713 0.00747
    Other, Net 0 0
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Total Current Assets 35.968 34.911 37.386 30.549 30.86
    Cash and Short Term Investments 26.618 25.623 27.316 20.012 21.326
    Cash 26.618 25.623 27.316 20.012 21.326
    Total Receivables, Net 6.494 6.757 7.288 7.068 6.871
    Accounts Receivable - Trade, Net 5.968 5.268 5.631 6.031 4.749
    Total Inventory 1.961 1.828 1.8 1.694 1.521
    Prepaid Expenses 0.895 0.703 0.982 1.775 1.142
    Total Assets 201.837 190.538 197.618 181.844 167.631
    Property/Plant/Equipment, Total - Net 19.639 16.657 20.749 13.652 13.506
    Intangibles, Net 0.563 0.811 0.82 0.442 0
    Long Term Investments 19.786 11.5 8.902 7.356 1.532
    Note Receivable - Long Term 1.639 2.828 2.906 2.9 1.495
    Other Long Term Assets, Total 0.829 0.73 0.754 0.844 1.039
    Total Current Liabilities 26.471 29.368 40.67 37.804 33.518
    Accounts Payable 2.075 1.886 2.12 1.648 1.912
    Notes Payable/Short Term Debt 0 0 9.201 0 0
    Current Port. of LT Debt/Capital Leases 6.298 10.441 11.589 6.219 3.21
    Other Current Liabilities, Total 8.692 8.325 17.76 29.937 28.396
    Total Liabilities 33.888 36.454 51.667 51.066 59.348
    Total Long Term Debt 7.888 6.992 11.092 11.704 8.272
    Long Term Debt 2.188 3.649 5.295 9.98 7.375
    Capital Lease Obligations 5.7 3.343 5.797 1.724 0.897
    Deferred Income Tax 0.532 0.259 0.228 0.17 0.103
    Minority Interest -1.411 -0.573 -0.702 -0.45 0.05
    Other Liabilities, Total 0.408 0.408 0.379 1.838 17.405
    Total Equity 167.949 154.084 145.951 130.778 108.283
    Common Stock 121.028 119.838 119.789 118.918 108.738
    Retained Earnings (Accumulated Deficit) 47.594 33.243 26.246 12.502 -0.343
    Other Equity, Total -0.623 -0.261 -0.042 -0.642 -0.112
    Total Liabilities & Shareholders’ Equity 201.837 190.538 197.618 181.844 167.631
    Total Common Shares Outstanding 486.382 482.61 482.882 459.415 459.416
    Property/Plant/Equipment, Total - Gross 35.243 31.973 35.222 27.802 23.967
    Accumulated Depreciation, Total -15.604 -15.316 -14.473 -14.15 -10.461
    Goodwill, Net 123.413 123.101 126.101 126.101 119.199
    Treasury Stock - Common -0.05 -0.089 -0.042
    Accrued Expenses 9.406 8.716
    Unrealized Gain (Loss) 0 1.353
    Dec 2021 Jun 2021 Dec 2020 Jun 2020 Dec 2019
    Total Current Assets 35.968 34.149 34.911 29.304 37.386
    Cash and Short Term Investments 26.618 24.665 25.623 20.254 27.316
    Cash 26.618 24.665 25.623 20.254 27.316
    Total Receivables, Net 6.494 6.421 6.757 5.904 7.288
    Accounts Receivable - Trade, Net 5.968 5.537 5.268 4.218 5.631
    Total Inventory 1.961 1.864 1.828 2.09 1.8
    Prepaid Expenses 0.895 1.199 0.703 1.056 0.982
    Total Assets 201.837 188.331 190.538 192.079 197.618
    Property/Plant/Equipment, Total - Net 19.639 15.669 16.657 23.118 20.749
    Intangibles, Net 123.976 123.917 123.912 126.828 126.921
    Long Term Investments 19.786 11.026 11.5 9.416 8.902
    Note Receivable - Long Term 1.639 2.843 2.828 2.643 2.906
    Other Long Term Assets, Total 0.829 0.727 0.73 0.77 0.754
    Total Current Liabilities 26.471 24.42 29.368 33.046 40.67
    Accounts Payable 2.075 1.981 1.886 2.436 2.12
    Notes Payable/Short Term Debt 0 0 0 0 9.201
    Current Port. of LT Debt/Capital Leases 6.298 7.653 10.441 10.54 11.589
    Other Current Liabilities, Total 18.098 14.786 17.041 20.07 17.76
    Total Liabilities 33.888 29.617 36.454 45.009 51.667
    Total Long Term Debt 7.888 4.572 6.992 11.962 11.092
    Long Term Debt 2.188 2.599 3.649 2.789 5.295
    Capital Lease Obligations 5.7 1.973 3.343 9.173 5.797
    Deferred Income Tax 0.532 0.366 0.259 0.295 0.228
    Minority Interest -1.411 -0.149 -0.573 -0.673 -0.702
    Other Liabilities, Total 0.408 0.408 0.408 0.379 0.379
    Total Equity 167.949 158.714 154.084 147.07 145.951
    Common Stock 121.028 119.888 119.838 119.836 119.789
    Retained Earnings (Accumulated Deficit) 47.594 38.497 33.243 27.842 26.246
    Treasury Stock - Common -0.05 -0.05 -0.089 -0.089 -0.042
    Other Equity, Total -0.623 -0.39 -0.261 -0.519 -0.042
    Total Liabilities & Shareholders’ Equity 201.837 188.331 190.538 192.079 197.618
    Total Common Shares Outstanding 486.382 482.789 482.61 482.611 482.882
    Unrealized Gain (Loss) 0 0.769 1.353
    • Annual
    • Quarterly
    2021 2020 2019 2018 2017
    Net income/Starting Line 18.07 10.528 16.069 14.104 9.483
    Cash From Operating Activities 24.467 20.907 26.109 17.44 12.788
    Cash From Operating Activities 8.915 8.959 8.933 3.882 2.646
    Non-Cash Items -1.794 2.444 1.527 1.174 1.008
    Cash Interest Paid 0.488 1.199 1.003 0.76 0.471
    Changes in Working Capital -1.177 -1.389 -0.665 -1.8 -0.349
    Cash From Investing Activities -9.688 -3.365 -18.745 -28.682 -22.223
    Capital Expenditures -4.229 -1.572 -2.143 -3.42 -5.014
    Other Investing Cash Flow Items, Total -5.459 -1.793 -16.602 -25.262 -17.209
    Cash From Financing Activities -13.784 -19.235 -0.06 9.953 22.937
    Financing Cash Flow Items -1.063 -0.3 -0.38 -0.537 -0.627
    Issuance (Retirement) of Stock, Net 0.553 -0.084 0.676 7.088 15.933
    Issuance (Retirement) of Debt, Net -11.344 -16.921 -0.356 3.402 7.631
    Net Change in Cash 0.995 -1.693 7.304 -1.289 13.502
    Amortization 0.453 0.365 0.245 0.08 0
    Cash Taxes Paid 2.018 1.418 1.888 0.924 0.091
    Total Cash Dividends Paid -1.93 -1.93
    Dec 2021 Jun 2021 Dec 2020 Jun 2020 Dec 2019
    Net income/Starting Line 18.07 8.944 10.528 4.095 16.069
    Cash From Operating Activities 24.467 9.8 20.907 9.794 26.109
    Cash From Operating Activities 8.915 4.385 8.959 4.513 8.933
    Amortization 0.453 0.187 0.365 0.168 0.245
    Non-Cash Items -1.794 0.166 2.444 1.126 1.527
    Cash Taxes Paid 2.018 1.671 1.418 0.057 1.888
    Cash Interest Paid 0.488 0.278 1.199 0.806 1.003
    Changes in Working Capital -1.177 -3.882 -1.389 -0.108 -0.665
    Cash From Investing Activities -9.688 -3.194 -3.365 -0.928 -18.745
    Capital Expenditures -4.229 -3.212 -1.572 -0.525 -2.143
    Other Investing Cash Flow Items, Total -5.459 0.018 -1.793 -0.403 -16.602
    Cash From Financing Activities -13.784 -7.564 -19.235 -15.928 -0.06
    Financing Cash Flow Items -1.063 -0.16 -0.3 -0.38
    Issuance (Retirement) of Stock, Net 0.553 0 -0.084 -0.084 0.676
    Issuance (Retirement) of Debt, Net -11.344 -5.474 -16.921 -15.844 -0.356
    Net Change in Cash 0.995 -0.958 -1.693 -7.062 7.304
    Total Cash Dividends Paid -1.93 -1.93 -1.93

    SingMedical Company profile

    About Singapore Medical Group Ltd

    Singapore Medical Group Limited is a Singapore-based company that is engaged in the operation of medical clinics, provision of general medical services and investment holdings. The Company operates through three segments. The Health Business segment consists of obstetrical and gynecological services; oncology services including the prevention, diagnosis and treatment of cancer, cancer screening and cancer genetic and risk assessment; pediatrics services; general medicine and health screening services; cardiology services, and endocrinology services. The Diagnostic & Aesthetics Business segment consists of radiology and diagnostic imaging services; refractive surgery services; dental services including general dental services, prosthodontics, orthodontics, implant dentistry, oral surgery and gum treatment, and aesthetics medicine services. Its Others segment consists of group-level corporate services as well as business consultancy functions and telemedicine services.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Singapore Medical Group Ltd revenues increased 15% to SP$100.8M. Net income increased 79% to SP$15.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Interest Expense decrease of 74% to SP$159K (expense), Share of results of joint ventures and a increase of 98% to SP$898K (income).

    Equity composition

    01/2014, Rights Issue, 1 new shares for every 2 shares held @ 0.105 SGD (Factor: 1.058824).12/2014, Rights Issue, 1 new share for every 10 shares held @ SGD 0.153 Factor(1.0)

    Industry: Healthcare Facilities & Services (NEC)

    1004 Toa Payoh North
    Floor 06 Unit 03 07
    318995
    SG

    News

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    Cable coils near lows ahead of Fed and BoE rate decisions

    It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

    14:16, 19 September 2023

    FTSE 100 Technical Outlook - 18 September 2023

    In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

    06:55, 19 September 2023
    View of the City of London’s illuminated financial district skyline at dusk

    Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

    The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

    13:46, 15 September 2023

    People also watch

    XRP/USD

    0.52 Price
    -0.110% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01192

    ETH/USD

    1,594.81 Price
    +0.080% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 5.40

    US100

    14,710.90 Price
    +0.190% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0039%
    Overnight fee time 21:00 (UTC)
    Spread 7.0

    BTC/USD

    26,619.15 Price
    +0.150% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 85.00

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading